Nosiheptide

Nosiheptide

CAT N°: 17094
Price:

From 45.00 38.25

Nosiheptide is a thiopeptide antibiotic that inhibits bacterial protein synthesis by interfering with the function of elongation factors.{27776,27778} It is effective against many different methicillin-resistant S. aureus strains (MICs ? 0.25 mg/L), Enterococcus spp (MICs ? 0.125 mg/L), and the BI strain of C. difficile (MIC = 0.008 mg/L) but inactive against most Gram-negative bacteria.{27777}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-[1-(aminocarbonyl)ethenyl]-2-[(11S,14Z,21S,23S,29S)-14-ethylidene-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-3,23-dihydroxy-11-[(1R)-1-hydroxyethyl]-31-methyl-9,12,19,24,33,43-hexaoxo-30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-([2,4]-endothiazolomethanimino)-4-thiazolecarboxamide
  • Correlated keywords
    • thiopeptide antibiotic inhibitor protein synthesis MRSA VRE infectious disease biochemical 11057-08-2 51668-49-6 65454-47-9 Primofax NSC307240 RP9671 inhibit bacterial elongation factor methicillin-resistant S aureus Staphylococcus Enterococcus BI strain C difficile Clostridium
  • Product Overview:
    Nosiheptide is a thiopeptide antibiotic that inhibits bacterial protein synthesis by interfering with the function of elongation factors.{27776,27778} It is effective against many different methicillin-resistant S. aureus strains (MICs ? 0.25 mg/L), Enterococcus spp (MICs ? 0.125 mg/L), and the BI strain of C. difficile (MIC = 0.008 mg/L) but inactive against most Gram-negative bacteria.{27777}

We also advise you